Steven I Park Selected Research

Steven I Park Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 07/2010
13	Lymphoma (Lymphomas) 07/2021 - 11/2007
7	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 06/2016
6	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2021 - 04/2017
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 12/2011
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 11/2016
3	Hematologic Neoplasms (Hematological Malignancy) 07/2021 - 11/2007
3	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2020 - 04/2017
3	Hodgkin Disease (Hodgkin's Disease) 01/2020 - 12/2013
3	B-Cell Lymphoma (Lymphoma, B Cell) 12/2018 - 11/2007
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2020 - 01/2019
2	Exanthema (Rash) 04/2017 - 11/2016
2	Leukemia 03/2011 - 08/2009
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 07/2021
1	Anemia 07/2021
1	Deglutition Disorders (Dysphagia) 07/2021
1	Dementia (Dementias) 07/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 07/2021
1	Drug Eruptions (Drug Eruption) 01/2020
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020
1	Mycosis Fungoides 01/2020
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2020
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2020
1	Disease Progression 10/2019
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2019
1	Plasmablastic Lymphoma 01/2018
1	T-Cell Leukemia (Leukemia, T Cell) 11/2017
1	Fever (Fevers) 04/2017
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 04/2017
1	Hypotension (Low Blood Pressure) 04/2017
1	Infections 04/2017
1	Syncope (Fainting) 12/2013
1	Pulmonary Embolism 12/2013
1	Fatigue 12/2013

Drug/Important Bio-Agent (IBA)

8	Rituximab (Mabthera)FDA Link 01/2022 - 06/2016
7	Proteins (Proteins, Gene)FDA Link 10/2019 - 07/2010
6	StreptavidinIBA 11/2017 - 05/2009
5	procaine isothiocyanate (PRIT)IBA 01/2018 - 08/2009
5	Biotin (Vitamin H)FDA Link 11/2017 - 07/2010
3	Lenalidomide (CC 5013)FDA Link 01/2022 - 11/2016
3	AntibodiesIBA 01/2022 - 05/2009
3	ibrutinibIBA 01/2022 - 11/2016
3	HLA-DR Antigens (HLA-DR)IBA 01/2020 - 05/2009
3	LigandsIBA 01/2019 - 03/2011
3	DOTA-biotin (90Y-DOTA-biotin)IBA 11/2010 - 05/2009
2	AzidesIBA 01/2020 - 01/2018
2	AntigensIBA 01/2020 - 01/2019
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2019 - 01/2018
2	Aurora Kinase AIBA 10/2019 - 12/2018
2	MLN 8237IBA 10/2019 - 12/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 01/2018
2	Vincristine (Oncovin)FDA LinkGeneric 12/2018 - 01/2018
2	Surface Antigens (Surface Antigen)IBA 10/2017 - 05/2009
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2017 - 01/2015
2	Brentuximab VedotinIBA 01/2017 - 12/2013
2	Radioisotopes (Radionuclides)IBA 07/2011 - 11/2010
1	atezolizumabIBA 01/2022
1	obinutuzumabIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 07/2021
1	Agammaglobulinaemia Tyrosine KinaseIBA 07/2021
1	TabletsIBA 07/2021
1	fludarabineIBA 11/2020
1	Chimeric Antigen ReceptorsIBA 11/2020
1	Drug CarriersIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	mogamulizumabIBA 01/2020
1	dactolisibIBA 01/2020
1	CCR4 ReceptorsIBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 10/2019
1	Trypan Blue FDA Link 10/2019
1	Annexin A5IBA 10/2019
1	Propidium (Propidium Iodide)IBA 10/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019
1	Anaplastic Lymphoma KinaseIBA 01/2019
1	Immunoconjugates (Immunoconjugate)IBA 01/2019
1	pyrrolo(2,1-c)(1,4)benzodiazepineIBA 01/2019
1	dibenzylcyclooctyneIBA 01/2018
1	Etoposide (VP 16)FDA LinkGeneric 01/2018
1	Bortezomib (Velcade)FDA Link 01/2018
1	Complement System Proteins (Complement)IBA 01/2018
1	Dendrimers (Dendrons)IBA 01/2018
1	Prednisone (Sone)FDA LinkGeneric 01/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2017
1	tumor-associated antigen 72IBA 11/2017
1	Glycoproteins (Glycoprotein)IBA 10/2017
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2017
1	Alanine Transaminase (SGPT)IBA 04/2017
1	Cytotoxins (Cytolysins)IBA 04/2017
1	idelalisibIBA 04/2017
1	Bendamustine Hydrochloride FDA Link 10/2016
1	TOR Serine-Threonine KinasesIBA 01/2015
1	Mitogen-Activated Protein KinasesIBA 01/2015

Therapy/Procedure

15	Therapeutics 09/2021 - 05/2009
6	Radioimmunotherapy 01/2018 - 11/2007
3	Drug Therapy (Chemotherapy) 01/2020 - 05/2009
3	Radiotherapy 01/2019 - 05/2009
3	Stem Cell Transplantation 01/2019 - 12/2013
1	Immunotherapy 01/2020
1	Drug Tapering 11/2016